Skip to main content

Programme

The educational programme features sessions presented by each global society.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and the British Society for Allergy & Clinical Immunology (BSACI). The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 5.00 AMA PRA Category 5 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please note all programme times are Greenwich Mean Time (GMT)

View live stream
TIMEPROGRAMME
08.00 – 08.05WELCOME

Chairs: Bryan Martin & George Gkimpas
08.05 – 08.20Updated grading system for systemic allergic reactions

A review looking at a unified grading scale for systemic allergic reactions due to allergen immunotherapy which can be applied across research and clinical practice.

Paul Turner

08.20 – 08.35Penicillin delabeling Pathways

Learn about initiatives to remove false penicillin allergy labels in an effort to reduce antimicrobial resistance which is one of the greatest threats to global health.

Lene Garvey

08.35 – 08.50Chronic cough: An allergy and ENT perspective

This talk discusses the aetiology of chronic cough including hypersensitivity of the cough reflex. Promising treatments on offer include ATP receptor antagonists.

Philip Rouadi

08.50 – 09.05Panel Q&A
09:05 – 09:20BREAK
09.20 – 10.20COMPANY SYMPOSIUM
transparentEACCI-logo-tran
Chairs: Mohammed Shamji & Claudia Gore
10.20 – 10.35Management of hereditary angioedema

The management of Hereditary Angioedema has significantly advanced over the past two decades. Hear about the modern theapies available worldwide to improve disease control and quality of life.

Maria Teresa Cabellero

10.35 – 10.50Highlights from the AACI/ENDA position paper on drug provocation testing

In drug hypersensitivity, drug provocation testing (DPT) is the gold standard for diagnosis. This position paper provides guidelines for optimizing DPT use, ensuring safety while maximizing available resources, and avoiding unnecessary procedures.

Annick Barbaud

10.50 – 11.05Nutritional and dietary interventions in children with atopic dermatitis without food allergy

This session focuses on how nutrition may improve atopic dermatitis, without necessarily avoiding food allergens.

Carina Venter

11.05 – 11.20Panel Q&A
11.20 – 11.40BREAK
11.40 – 13.00Presidents’ Forum

This is the only worldwide platform where presidents of 5 global societies meet to discuss topics of interest in the field of allergic disease. It provides an oppurtunity to ask questions to the presidents.

Session-linked discussion
Chair: Syed Hasan Arshad
Speakers:
For BSACI: Dr Robin Gore
For EAACI: Professor Maria Torres
For WAO: Professor Mario Morais Almeida
For AAAAI: Professor Paul Williams
For ALLSA: Dr Sarah Karabus

13.00 – 14.00BREAK
transparentBSACI-logo-tran
Chairs: Leanne Goh & Graham Roberts
14.00 – 14.20Challenging food allergy cases

Adam Fox presents 2 challenging food allergy case studies prompting us to reflect on how to provide rapid and high quality allergy services.

Adam Fox

14.20 – 14.40A not-so-straightforward referral

Learn about the important role allergy nurses provide across the allergic diseases spectrum.

Phoebe Moulsdale

14.40 – 15.00Challenging immunodeficiency cases

In this session Andrew Gennery discusses diagnostic and therapeutic dilemmas in managing patients with inborn errors of immunity.

Andrew Gennery

15.00 – 15.20Panel Q&A
15.20 – 15.55BREAK
transparentBSACI-logo-tran
Chair: Nicola Brathwaite
15.55 – 16.10When it’s not a duck – FPIES masquerading as malnutrition

This session presents a case of FPIES masquerading as malnutrition in a sick child. Learn how to recognise unusual presentations of food allergy in developing countries with high burden of infectious diseases.

Candice Royal

16.10 – 16.25Can alpha gal allergy be predicted using IgE levels?

In this session Michael Levin reviews alpha-gal allergy presentation, diagnosis and explores the mechanisms of food allergies.

Michael Levin

16.25 – 16.40Unique insights on Severe Cutaneous Allergic Reactions (SCAR) from TB and HIV endemic settings

This session discusses immunopathogenesis, genetic risks and novel diagnostic approaches to SCAR in a TB/ HIV endemic setting.

Jonny Peter

16.40 – 16.55Panel Q&A
16.55 – 17.10BREAK
transparent
AAAAI-logo-tran
Chairs: Christina Jones & Frank Virant
17.10 – 17.25Anaphylaxis Practice Parameters Highlights

A review of anaphylaxis practice parameters including diagnostic criteria in infants, investigating possible HaT or mastocytosis, need for emergency services after AAI use and risk of b-blockers and ACE inhibitors in immunotherapy.

David Golden

17.25 – 17.40Urticaria Practice Parameter highlights

Chronic urticaria is common with many emerging phenotypes/ endotypes. Jonathan Bernstein reviews diagnosis, treatment and monitoring of chronic urticaria to ensure optimal outcomes.

Jonathan Bernstein

17.40 – 17.55Immunotherapy Practice Parameter highlights

In this session Anne Ellis will share updates on new developments in the Immunotherapy Practice Parameters from the Immunotherapy working group.

Anne Ellis

17.55 – 18.10Panel Q&A
18.10 – 18.15CLOSING AND PRESIDENTS’ REMARKS